ALLMedicine™ Cavernous Sinus Thrombosis Center
Research & Reviews 113 results
https://doi.org/10.1097/SCS.0000000000008680
The Journal of Craniofacial Surgery; Shukhrat BA, Dar-Odeh N et. al.
Jun 28th, 2022 - A heavy burden of cranio-maxillofacial complications may be encountered in corona virus disease-2019 patients due to the associated coagulopathy and inflammatory consequences of the disease. This study aims to describe clinical and radiographic fe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913101
Medicine Kim JM, Kang KW et. al.
Apr 23rd, 2022 - Septic cavernous sinus thrombosis (SCST) is a rare but life-threatening condition that commonly arises from infections, including paranasal sinusitis, otitis media, and skin infection. Meanwhile, head trauma as a predisposing factor of SCST has be...
https://emedicine.medscape.com/article/994550-differential
Apr 7th, 2022 - Diagnostic Considerations Failure to recognize necrotizing (ie, malignant) otitis externa (OE) is a significant pitfall. A patient who is diabetic or immunocompromised with severe pain in the ear should have necrotizing OE excluded by an otolaryng...
https://doi.org/10.1016/j.pediatrneurol.2022.02.006
Pediatric Neurology; Karakas C, Hajiyev Y et. al.
Mar 21st, 2022 - Pediatric cavernous sinus thrombosis (CST) is a rare condition with limited data regarding its clinical characteristics and long-term outcomes. The objective of this study was to describe the clinical and radiologic features, diagnostic evaluation...
https://doi.org/10.1097/PAF.0000000000000752
The American Journal of Forensic Medicine and Pathology; Podduturi V, Guileyardo JM
Mar 8th, 2022 - Cavernous sinus thrombosis is a rare and often fatal condition, usually associated with infections in the head and neck region. Clinical presentation includes fever, headache, and periorbital swelling. Mortality can be high; however, prompt treatm...
News 4 results
https://www.medscape.com/viewarticle/917986
Sep 9th, 2019 - Infection with Candida auris likely led to panophthalmitis and vision loss in an immune compromised patient, according to a case report published online today in the Annals of Internal Medicine. Vinayak Shenoy, DO, and colleagues at Lenox Hill Hos...
https://www.mdedge.com/familymedicine/article/142113/bleeding-disorders/prophylactic-emicizumab-cut-bleeds-87-hemophilia
Hematology News; Amy Karon
Jul 10th, 2017 - Once-weekly prophylactic therapy with emicizumab (ACE910) was associated an 87% lower rate of treated bleeding than no prophylaxis among patients with hemophilia A with inhibitors in the open-label, phase III HAVEN 1 trial. After a median 24 weeks.
https://www.mdedge.com/pediatrics/article/142113/bleeding-disorders/prophylactic-emicizumab-cut-bleeds-87-hemophilia
Amy Karon
Jul 10th, 2017 - Once-weekly prophylactic therapy with emicizumab (ACE910) was associated an 87% lower rate of treated bleeding than no prophylaxis among patients with hemophilia A with inhibitors in the open-label, phase III HAVEN 1 trial. After a median 24 weeks.
https://www.mdedge.com/familymedicine/article/106280/dermatology/severely-swollen-eye
The Journal of Family Practice;
Feb 2nd, 2016 - This patient had a severe case of periorbital cellulitis. The ENT doctor ordered a computed tomography scan of the sinuses, which showed ethmoid and maxillary sinusitis on the right side with some proptosis.